ArticleESMO open2019

Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases.

Yanina J L Jansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.